deferasorox

Generic: deferasirox

Labeler: novadoz pharmaceuticals llc
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name deferasorox
Generic Name deferasirox
Labeler novadoz pharmaceuticals llc
Dosage Form GRANULE
Routes
ORAL
Active Ingredients

deferasirox 180 mg/1

Manufacturer
Novadoz Pharmaceuticals LLC

Identifiers & Regulatory

Product NDC 72205-075
Product ID 72205-075_b2ff1a76-b564-4235-8275-89005d9c4a24
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA214650
Listing Expiration 2026-12-31
Marketing Start 2021-03-18

Pharmacologic Class

Established (EPC)
iron chelator [epc]
Mechanism of Action
iron chelating activity [moa] cytochrome p450 3a4 inducers [moa] cytochrome p450 2c8 inhibitors [moa] cytochrome p450 1a2 inhibitors [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 72205075
Hyphenated Format 72205-075

Supplemental Identifiers

RxCUI
1923822 1923826 1923828
UPC
0372205076617 0372205176614 0372205075610
UNII
V8G4MOF2V9
NUI
N0000000144 N0000175522 N0000185506 N0000187062 N0000182138

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name deferasorox (source: ndc)
Generic Name deferasirox (source: ndc)
Application Number ANDA214650 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 180 mg/1
source: ndc
Packaging
  • 30 PACKET in 1 CARTON (72205-075-30) / 1 GRANULE in 1 PACKET (72205-075-61)
source: ndc

Packages (1)

Ingredients (1)

deferasirox (180 mg/1)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "b2ff1a76-b564-4235-8275-89005d9c4a24", "openfda": {"nui": ["N0000000144", "N0000175522", "N0000185506", "N0000187062", "N0000182138"], "upc": ["0372205076617", "0372205176614", "0372205075610"], "unii": ["V8G4MOF2V9"], "rxcui": ["1923822", "1923826", "1923828"], "spl_set_id": ["1122f1c0-c160-49db-a31b-90d7521370f5"], "pharm_class_epc": ["Iron Chelator [EPC]"], "pharm_class_moa": ["Iron Chelating Activity [MoA]", "Cytochrome P450 3A4 Inducers [MoA]", "Cytochrome P450 2C8 Inhibitors [MoA]", "Cytochrome P450 1A2 Inhibitors [MoA]"], "manufacturer_name": ["Novadoz Pharmaceuticals LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 PACKET in 1 CARTON (72205-075-30)  / 1 GRANULE in 1 PACKET (72205-075-61)", "package_ndc": "72205-075-30", "marketing_start_date": "20210318"}], "brand_name": "Deferasorox", "product_id": "72205-075_b2ff1a76-b564-4235-8275-89005d9c4a24", "dosage_form": "GRANULE", "pharm_class": ["Cytochrome P450 1A2 Inhibitors [MoA]", "Cytochrome P450 2C8 Inhibitors [MoA]", "Cytochrome P450 3A4 Inducers [MoA]", "Iron Chelating Activity [MoA]", "Iron Chelator [EPC]"], "product_ndc": "72205-075", "generic_name": "Deferasirox", "labeler_name": "Novadoz Pharmaceuticals LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Deferasorox", "active_ingredients": [{"name": "DEFERASIROX", "strength": "180 mg/1"}], "application_number": "ANDA214650", "marketing_category": "ANDA", "marketing_start_date": "20210318", "listing_expiration_date": "20261231"}